rtPA and Fe3O4 MNP were encapsulated in thermosensitive magnetic liposome (TML). RSM could predict the drug encapsulation efficiency and temperature-sensitive drug release from TML. Temperature-sensitive release of rtPA was confirmed from in vitro thrombolysis experiments. TML-rtPA will be useful as a magnetic targeted nanodrug to improve clinical thrombolytic therapy.